OUTCOME AND SAFETY OF RECANALIZATION TREATMENTS IN ISCHEMIC STROKE DUE TO ACUTE BASILAR ARTERY OCCLUSION

Sponsor
115 People's Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05402878
Collaborator
(none)
150
1
29
5.2

Study Details

Study Description

Brief Summary

Rationale: Recently, two prospective multicenter RCT reported a potential beneficial effect of endovascular thrombectomy (EVT) in patients with an acute symptomatic basilar artery occlusion (BAO). However, the high rate of crossover in BEST study and the long-term of recruitment in BASICS study influenced the validity of the results.

Objective: To assess the outcomes and prognostic factors of recanalization therapy in patients with BAO, caused by a CTA/MRA/DSA confirmed occlusion of the basilar artery.

Study design: This is a prospective observational study. Study population: Patients with acute ischemic stroke and a confirmed basilar artery occlusion by CTA/MRA/DSA.

Main study parameters/outcomes: Favorable outcome at day 90 defined as a modified Rankin Score (mRS - functional scale) of 0-3. The estimate will be adjusted for the known prognostic variables age, time from onset to treatment, stroke severity (NIHSS), PC ASPECT and collateral flow and adjusted and unadjusted estimates with corresponding 95% confidence intervals will be reported.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Acute basilar artery thrombosis is associated with a poor prognosis. Prevalence of basilar artery occlusion are not known in Vietnam.Various treatments were tried in groups of patients with acute ischemic stroke due to basilar artery occlusion, but evidence based was not cleared previous studies. Therefore, we conduct this study to evaluate the efficacy and safety of recanalization therapies, which included intravenous thrombosis alone, endovascular alone, or bridging IVT and endovascular, in basilar artery occlusion stroke patients.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    150 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    RECANALISATION THERAPY IN ISCHEMIC STROKE DUE TO BASILAR ARTERY OCCLUSION IN PEOPLE 115 HOSPITAL, VIETNAM
    Actual Study Start Date :
    Aug 1, 2021
    Anticipated Primary Completion Date :
    Dec 31, 2023
    Anticipated Study Completion Date :
    Dec 31, 2023

    Outcome Measures

    Primary Outcome Measures

    1. favourable outcome [90 (± 14 days) after procedure]

      a modified Rankin Score of 0-3

    Secondary Outcome Measures

    1. good outcome [90 (± 14 days) after procedure]

      a modified Rankin Score of 0-2

    2. mortality [90 (± 14 days) after procedure]

      Number of subjects who died at 90-day follow-up/total number of subjects who participated in 90-day follow-up) x100%.

    3. Dichotomized mRS score [90 (± 14 days) after procedure]

      mRS (0-2 versus 3-6 and 0-4 versus 5-6 )

    4. Symptomatic intracerebral hemorrhage (sICH) [within 72 hours after procedure]

      SICH means any hemorrhage with neurological deterioration, as indicated by an NIHSS score that was higher by ≥4 points than the value at baseline or the lowest value in the first 72 hours or any hemorrhage leading to death.

    5. Any intracerebral hemorrhage [within 72 hours after procedure]

      intracerebral hemorrhage was defined according ECASS definition.

    6. Procedural related complications [Perioperative period]

      arterial perforation, arterial dissection, embolization in a previously uninvolved vascular territory and so on

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Symptoms and signs compatible with ischemia in the basilar artery territory.

    • Basilar artery occlusion (BAO) confirmed by CTA or MRA or DSA.

    • Age 18 years or older

    • Patients were treated with one of these among therapies IVT alone, bridging IVT and thrombectomy or thrombectomy alone..

    Exclusion Criteria:
    • Patients did not agree to enroll.
    Imaging exclusion criteria:
    • High-density lesion consistent with hemorrhage of any degree

    • Significant cerebellar mass effect or acute hydrocephalus

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 People 115 Hospital Ho Chi Minh Ho Chi Minh City Vietnam 70000

    Sponsors and Collaborators

    • 115 People's Hospital

    Investigators

    • Study Director: Huy Thang Nguyen, Professor, People 115 Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    NGUYEN THI BICH HUONG, Investigator, 115 People's Hospital
    ClinicalTrials.gov Identifier:
    NCT05402878
    Other Study ID Numbers:
    • People 115 Hospital
    First Posted:
    Jun 2, 2022
    Last Update Posted:
    Jul 26, 2022
    Last Verified:
    Jul 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by NGUYEN THI BICH HUONG, Investigator, 115 People's Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 26, 2022